In our study, we observed that following MD patients’ treatment with Pred, there is an increase in intermediate monocyte subsets expressing CD163 and CD206, as has been shown in other steroid-treated disorders, and this is related to the attenuation of T cell responses [63,66]. Here, CD163 is linked to Menkes disease.